Synopsis of recent research by authors named "Saba S Shaikh"
- Saba S Shaikh has focused her recent research on the clinical outcomes and safety of treatments in various types of cancers, particularly metastatic triple-negative breast cancer (mTNBC) and early-stage triple-negative breast cancer (TNBC), exploring the real-world effectiveness of therapies like sacituzumab govitecan and pembrolizumab.
- A significant finding from her studies indicates that chemotherapy dose reductions or discontinuation adversely affect patient outcomes in early-stage TNBC treated with neoadjuvant chemotherapy, emphasizing the need for adherence to treatment protocols to maximize survival benefits.
- Additionally, Shaikh's work includes recommendations for optimal practices in early detection and prognostic assessment of cutaneous melanoma, highlighting the role of gene expression profile testing in improving patient outcomes in this area.
